Pandemic Effect on Healthcare Use and Death in Adults with Epilepsy: A Population Study
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024
DOI: 10.1017/cjn.2023.316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Maria Espinoza Vargas und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Ottawa Hospital Research Institute, Ottawa, ON, Canada. Hauptthemen laut MEDLINE: Epilepsy, COVID-19, Patient Acceptance of Health Care, Hospitalization. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
We conducted a population-based study using Ontario health administrative data to describe trends in healthcare utilization and mortality in adults with epilepsy during the first pandemic year (March 2020–March 2021) compared to historical data (2016–2019). We also investigated if changes in outpatient visits and diagnostic testing during the first pandemic year were associated with increased risk for hospitalizations, emergency department (ED) visits, or death.
Methods
Projected monthly visit rates (per 100,000 people) for outpatient visits, electroencephalography, magnetic resonance, computed tomography, all-cause ED visits, hospitalizations, and mortality were calculated based on historical data by fitting monthly time series autoregressive integrated moving-average models. Two-way interactions were calculated using Quasi-Poisson models.
Results
In adults with epilepsy during the first quarter of the pandemic, we demonstrated a reduction in all-cause outpatient visits, diagnostic testing, ED visits and hospitalizations, and a temporary increase in mortality (observed rates of 355.8 vs projected 308.8, 95% CI: 276.3–345.1). By the end of the year, outpatient visits increased (85,535.4 vs 76,620.6, 95% CI: 71,546.9–82,059.4), and most of the diagnostic test rates returned to the projected. The increase in the rate of all-cause mortality during the pandemic, compared to pre-pandemic, was greater during months with the lower frequency of diagnostic tests than months with higher frequency (interaction p -values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- ICES, Ottawa, Toronto, ON, Canada.
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
- Research Institute, The Hospital of Sick Children, Toronto, ON, Canada.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
ORCID-Profile: Ryan Jason Gotfrit, Tetyana Kendzerska
Zitieren
APA
Vargas, M. E., Gershon, A. S., Pugliese, M., Gotfrit, R. J., Manuel, D., Sadatsafavi, M., Stukel, T. A., To, T., Kendall, C. E., Thavorn, K., Robillard, R., & Kendzerska, T. (2024). Pandemic Effect on Healthcare Use and Death in Adults with Epilepsy: A Population Study. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.316
Vancouver
Vargas ME, Gershon AS, Pugliese M, Gotfrit RJ, Manuel D, Sadatsafavi M, et al. Pandemic Effect on Healthcare Use and Death in Adults with Epilepsy: A Population Study. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2023.316
BibTeX
@article{Vargas2024,
author = {Vargas, Maria Espinoza and Gershon, Andrea S and Pugliese, Michael and Gotfrit, Ryan Jason and Manuel, Douglas and Sadatsafavi, Mohsen and Stukel, Therese A and To, Teresa and Kendall, Claire E and Thavorn, Kednapa and Robillard, Rebecca and Kendzerska, Tetyana},
title = {Pandemic Effect on Healthcare Use and Death in Adults with Epilepsy: A Population Study},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2024},
doi = {10.1017/cjn.2023.316}
}
EUVIMED